A Single-Center, Open-Label Study to Evaluate the Absorption, Metabolism, and Excretion of Single Doses of [14c]-Samidorphan in Healthy Male Subjects
Latest Information Update: 08 Sep 2019
At a glance
- Drugs Samidorphan (Primary) ; Samidorphan (Primary) ; Samidorphan (Primary)
- Indications Alcoholism; CNS disorders; Eating disorders; Substance-related disorders
- Focus Pharmacokinetics
- Sponsors Alkermes plc
- 29 Aug 2019 Results assessing clinical pharmacokinetic (PK) properties of SAM following different routes of administration published in the Drugs in R and D
- 01 Sep 2018 Results published in the Clinical Pharmacology in Drug Development
- 17 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.